![Chemical structure of 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid, CAS 4394-00-7](https://api.angenesci.com/structure/3095/4394-00-7.png)
No data
No data
No data
| CAS Number | 4394-00-7 |
| Catalog Number | AG003T3S(AGN-PC-07Y4SC) |
| Chemical Name | 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid |
| EC Number | 224-516-2 |
| IUPAC Name | 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid |
| InChI | InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20) |
| InChI Key | JZFPYUNJRRFVQU-UHFFFAOYSA-N |
| MDL Number | MFCD00010569 |
| Molecular Formula | C13H9F3N2O2 |
| Molecular Weight | 282.2180 |
| NSC Number | 758196 |
| SMILES | C1=C(C(=NC=C1)NC2=CC(=CC=C2)C(F)(F)F)C(O)=O |
| UNII | 4U5MP5IUD8 |
| Synonyms | Acid, Niflumic,
Donalgin,
Flunir,
Niflactol,
Niflugel,
Niflumic Acid,
Nifluril,
niflumic acid,
4394-00-7,
Nifluril,
Forenol,
Landruma,
Actol,
Acido niflumico,
Nifluminic acid,
Acide niflumique,
Acidum niflumicum,
Acide niflumique [INN-French],
Acido niflumico [INN-Spanish],
Acidum niflumicum [INN-Latin],
2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid,
Niflumate,
Acide niflumique [French],
Acido niflumico [Italian],
UP 83,
2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid,
2-(3-Trifluoromethylanilino)nicotinic Acid,
2-(3-(Trifluoromethyl)anilino)nicotinic acid,
2-[3-(Trifluoromethyl)anilino]nicotinic acid,
Lopac-N-0630,
UNII-4U5MP5IUD8,
SC 1332,
CCRIS 5740,
3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-,
2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid,
2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid,
2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID,
EINECS 224-516-2,
2-(3-Trifluoromethyl-phenylamino)-nicotinic acid,
2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID,
BRN 0489360,
4U5MP5IUD8,
MLS000069713,
NFL,
CHEBI:34888,
3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-,
Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino [French],
JZFPYUNJRRFVQU-UHFFFAOYSA-N,
2-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid,
MFCD00010569,
2-[alpha,alpha,alpha-trifluoro-m-toluidino]-nicotinic acid,
NCGC00015724-10,
Donalgin,
SMR000058199,
CAS-4394-00-7,
DSSTox_CID_3368,
2-(3-[Trifluoromethyl]anilino)nicotinic acid,
DSSTox_RID_76996,
2-(3-(Trifluoromethyl)phenylamino)nicotinic acid,
DSSTox_GSID_23368,
Nicotinic acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-,
Niflamol,
Niflam,
Niflumic acid [INN:DCF],
Niflugel (TN),
Niflumic acid (INN),
SR-01000000231,
2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid,
niflumic-acid,
NiflumicAcid,
ni-flumic acid,
Niflumic acid [INN:BAN:DCF],
Actol, analgesic,
Prestwick_890,
Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino,
PubChem21796,
Spectrum_001353,
1td7,
ACMC-209jvx,
Opera_ID_1746,
Prestwick0_000255,
Prestwick1_000255,
Prestwick2_000255,
Prestwick3_000255,
Spectrum2_000794,
Spectrum3_001485,
Spectrum4_000043,
Spectrum5_001216,
Niflumic acid (Hit 16),
N 0630,
AC1L1IA4,
2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid,
CBiol_001828,
Lopac0_000845,
SCHEMBL24706,
BSPBio_000070,
BSPBio_001393,
BSPBio_003069,
KBioGR_000113,
KBioGR_000505,
KBioSS_000113,
KBioSS_001833,
5-22-13-00598 (Beilstein Handbook Reference),
KSC587Q8N,
MLS001076327,
CHEMBL63323,
DivK1c_000277,
SPECTRUM1502015,
SPBio_000928,
SPBio_002289,
BPBio1_000078,
GTPL2439,
DTXSID1023368,
BDBM85507,
CTK4I7886,
HMS500N19,
KBio1_000277,
KBio2_000113,
KBio2_001833,
KBio2_002681,
KBio2_004401,
KBio2_005249,
KBio2_006969,
KBio3_000225,
KBio3_000226,
KBio3_002569,
NINDS_000277,
2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid,
Bio1_000114,
Bio1_000603,
Bio1_001092,
Bio2_000113,
Bio2_000593,
HMS1361F15,
HMS1568D12,
HMS1791F15,
HMS1921D12,
HMS1989F15,
HMS2090D19,
HMS2095D12,
HMS2234F11,
HMS3262J11,
HMS3374H01,
HMS3402F15,
HMS3649A08,
HMS3656P14,
HMS3712D12,
Pharmakon1600-01502015,
UP-83,
ZINC125031,
HY-B0493,
KS-00000CB5,
NSC_4488,
Tox21_110206,
Tox21_500845,
ANW-30043,
BBL003619,
CCG-40157,
DL-457,
Nicotinic acid, 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)-,
NSC758196,
s3018,
SBB001146,
STK803109,
AKOS000519590,
Tox21_110206_1,
AC-2652,
CS-2614,
DB04552,
GS-3202,
LP00845,
MCULE-3027710274,
NSC-758196,
RTR-017015,
IDI1_000277,
IDI1_033863,
NCGC00015724-01,
NCGC00015724-02,
NCGC00015724-03,
NCGC00015724-04,
NCGC00015724-05,
NCGC00015724-06,
NCGC00015724-07,
NCGC00015724-08,
NCGC00015724-09,
NCGC00015724-11,
NCGC00015724-12,
NCGC00015724-13,
NCGC00015724-14,
NCGC00015724-17,
NCGC00023636-03,
NCGC00023636-04,
NCGC00023636-05,
NCGC00023636-06,
NCGC00023636-07,
NCGC00023636-08,
NCGC00023636-09,
NCGC00261530-01,
AJ-11904,
AK-72979,
AN-13743,
BAS 00821161,
BC218927,
BR-72979,
LS-96639,
ST013871,
CAS_4394-00-7,
SBI-0050821.P003,
2(3'-trifluormethylanilino)-nicotinic acid,
AB0012229,
AB1004097,
2-(3-(Trifluoromethyl)anilino)nicotinicacid,
AB00052255,
AM20070143,
EU-0100845,
FT-0603659,
ST24027408,
SW197011-3,
T7852,
C13698,
D08275,
S00109,
AB00052255-17,
AB00052255_18,
AB00052255_19,
394N007,
SR-01000000231-2,
SR-01000000231-5,
SR-01000000231-6,
W-106215,
BRD-K98763141-001-04-3,
BRD-K98763141-001-06-8,
BRD-K98763141-001-17-5,
SR-01000000231-11,
2-[3-(Trifluoromethyl)anilino]-3-pyridinecarboxylic acid,
Niflumic acid, European Pharmacopoeia (EP) Reference Standard,
2-{[3-(trifluoromethyl)-phenyl]-amino}-3-pyridincarboxylic acid,
2-[3-(Trifluoromethyl)anilino]nicotinic acid; 2-(|A,|A,|A-Trifluoro-m-toluidino)nicotinic acid,
Flogovital,
Niflactol,
Niflugel,
Flunir,
Acid, Niflumic,
D00HGB,
Niflumic acid [DCF:INN],
C13H9F3N2O2,
UPSA Brand 1 of Niflumic Acid,
UPSA Brand 2 of Niflumic Acid,
2,4-Dichloro-5-fluoropyrimidine,
CID4488,
Upsamedica Brand of Niflumic Acid,
C13-H9-F3-N2-O2,
UPSA Conseil Brand of Niflumic Acid,
B1530,
T2353,
2-(A,A,A-Trifluoro-m-toluidino)nicotinic acid,
39690A,
D009544,
methyl 4-hydroxy-5,6-dihydro-2H-pyran-3-carboxylate,
2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid,
NFA,
439081-18-2,
910332-88-6,
na,
|
| Complexity | 349 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 282.062g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 20 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 282.222g/mol |
| Monoisotopic Mass | 282.062g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 62.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.7 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H302-H312-H315-H319-H332-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P261-P280-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

